Lobbyist information

Amount

Joseph Boncore

$0.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 09/30/2021 Limited to interactions with the executive branch (including but not limited to the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth, Office of the Attorney General, Center for Health Information and Analysis, and the Health Policy Commission), the following: Any and all regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012 and health care reform; and development or implementation of regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing, Massachusetts Life Sciences Center, research and development, taxation, drug safety, and green bio.

Robert Coughlin

$6,600.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2021 02/01/2021 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.

Susan Martin

$22,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2021 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.

Zachary Stanley

$44,800.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 02/01/2021 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.

Total salaries paid:      $73,400.00

Lobbyist Entity information

Amount

Foley Hoag LLP	$120,000.00
Employed Terminated 01/01/2021

McDermott, Quilty & Miller, LLP	$120,000.00
Employed Terminated 01/01/2021

Park Street Strategies, LLC	$120,000.00
Employed Terminated 01/01/2021

Smith, Costello & Crawford	$120,000.00
Employed Terminated 01/01/2021

Total salaries paid:      $480,000.00

Expenditures

Amount